IMS Health Holdings Inc

IMS Health — Q3 2015 Earnings Presentation

18 slides from IMS Health's earnings presentation, Oct 29, 2015

  1. Slide 1: IMS Health Q3 2015 Earnings Call

    IMS Health Q3 2015 Earnings Call October 29, 2015 0

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q3 2015 earnings call Safe Harbor Statement This presentation Thi t ti includes i l d “forward-looking “f d l ki statements”, t t t ” including i l di statements t t t regarding di future f t fi financial i l and d operating t

  3. Slide 3: 3rd Quarter Results

    3rd Quarter Results $M Revenue Adjusted EBITDA +23.0% +8.6% @ CFx @ CFx $735 $656 $218 $221 Q3 2015 Q3 2014 Q3 2015 Q3 2014 Note: Dollars are at actual foreign exchange rates. CFx is constant currency. EBITDA is “Adjusted EBITDA” as calculated in the appendix of this presentation 2 IMS Health Confid

  4. Slide 4: 3rd Quarter Offering Revenue

    3rd Quarter Offering Revenue Offering 3rd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Information $373 $382 8.9% (2.3%) Technology Services $362 $274 42.4% 31.9% Total $735 $656 23.0% 12.0% Note: Dollars are at actual foreign exchange rates 3 IMS Health Confidential

  5. Slide 5: 3rd Quarter Geographic Revenue

    3rd Quarter Geographic Revenue Geography 3rd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Developed Markets $614 $547 21.5% 12.2% Emerging Markets $121 $109 30.5% 11.2% Total $735 $656 23.0% 12.0% Note: Dollars are at actual foreign exchange rates Prior year adjusted to conform

  6. Slide 6: 3rd Quarter EBITDA

    3rd Quarter EBITDA 3rd Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Adjusted EBITDA (1) $218 $221 8.6% (1.5%) Adjusted EBITDA margin 29.6% 33.7% (396) bps (409) bps Note: Dollars are at actual foreign exchange rates (1) See reconciliations of non-GAAP items in appendix 5 IMS Hea

  7. Slide 7: 3rd Quarter P&L

    3rd Quarter P&L At reported FX rates $M (except per share data) 2015 2014 Net Income $43 $47 Diluted Earnings per Share $0.13 $0.14 Adjusted Net Income (1) $129 $125 Adjusted Diluted Earnings per Share (1) $0.38 $0.37 (1) See reconciliations of non-GAAP items in appendix 6 IMS Health Confidential

  8. Slide 8: Year-to-date Revenue

    Year-to-date Revenue Offering Year-to-date Versus Prior Year Constant $M 2015 2014 Reported Currency Information $1,101 $1,149 7.1% (4.2%) Technology Services $1 008 $1,008 $814 33 9% 33.9% 23 8% 23.8% Total $2,109 $1,963 18.3% 7.4% Geography Year-to-date Versus Prior Year Developed Markets $1,760 $

  9. Slide 9: Year-to-date P&L

    Year-to-date P&L $M (except per share data) 2015 2014 Adjusted EBITDA (1) $654 $664 Adjusted EBITDA margin 31.0% 33.8% Net Income / (Loss) $388 $(197) Diluted Earnings / (Loss) per Share $1 14 $1.14 $(0 63) $(0.63) Adjusted Net Income (1) $390 $329 Adjusted Diluted EPS (1) $1.15 $1.02 (1) See reconc

  10. Slide 10: 3rd Quarter Balance Sheet Items & Metrics

    3rd Quarter Balance Sheet Items & Metrics $M 2015 2014 Cash & Cash Equivalents q $394 $390 (1) Principal Balance of Debt (2) $4,296 $3,816 (1) Net Debt $3,902 $3,426 (1) Gross Leverage Ratio 5.0x 4.3x (1) Net Cash Provided by Operating Activities $111 $191 Capital Expenditures and Additions to Defer

  11. Slide 11: 2015 Guidance

    2015 Guidance Full-Year 2015 Revenue Growth Constant Currency 19 - 20% Reported (1) ~10% Adjusted EBITDA Growth Constant Currency ~11% Reported (1) ~1% Adjusted Net Income Growth Constant Currency 22 - 23% Reported (1) 10 - 11% Adjusted Diluted EPS Constant Currency 17 - 18% Reported (1) 5 - 6% (1)

  12. Slide 12: Q&A

    Q&A 11

  13. Slide 13: Appendix: Non-GAAP Financial Measures

    Appendix: A di Non-GAAP N GAAP Financial Measures 12

  14. Slide 14: Net Income (Loss) to Adjusted EBITDA

    Net Income (Loss) to Adjusted EBITDA Three Months Ended Nine Months Ended September 30, September 30, (in millions) 2015 2014 2015 2014 Net Income (Loss) $ 43 $ 47 $ 388 $ (197) Provision for ((benefit from)) income taxes 8 11 ((219)) ((141)) Other (income) loss, net (6) (7) (16) 281 Interest expens

  15. Slide 15: Net Income (Loss) to Adjusted Net Income & Per Share Data

    Net Income (Loss) to Adjusted Net Income & Per Share Data Three Months Ended Nine Months Ended September 30, September 30, (in millions, except per share data) 2015 2014 2015 2014 Net Income (Loss) $ 43 $ 47 $ 388 $ (197) Provision for (benefit from) income taxes 8 11 (219) (141) Amortization associ

  16. Slide 16: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended Nine Months Ended September 30, September 30, ((in millions)) 2015 2014 2015 2014 Net Cash Provided by (Used in) Operating Activities $ 111 $ 191 $ 326 $ (37) Capital expenditures (4) (14) (29) (59) Additions to computer software (34) (26) (87) (70) F Free

  17. Slide 17: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of September 30, 2015 $ 4,296 Adjusted EBITDA for the year ended December 31, 31 2014 878 Less: Adjusted EBITDA for the nine months ended September 30, 2014 (664) Add: Adjusted EBITDA for the nine months ended September 30, 2015 654 Adjusted EBITDA fo

  18. Slide 18: Non-GAAP Adjustments By Income Statement Line Items

    Non-GAAP Adjustments By Income Statement Line Items Three Months Th M th Ended E d d Nine M Ni Months th Ended E d d September 30, September 30, (in millions) 2015 2014 2015 2014 Non-GAAP adjustments included in: Operating costs of information, exclusive of depreciation and $ 1 $ 2 $ 3 $ 19 amortiza

IMS Health — Q3 2015 Earnings Presentation on 6ix